-
1
-
-
79851513969
-
Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery
-
Djärv T, Lagergren P (2011) Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery. Eur J Cancer 47:530-535
-
(2011)
Eur J Cancer
, vol.47
, pp. 530-535
-
-
Djärv, T.1
Lagergren, P.2
-
3
-
-
33751235250
-
Integration of HapMap-based SNP pattern analysis and gene expression profiling reveals common SNP profiles for cancer therapy outcome predictor genes
-
Glinsky GV (2006a) Integration of HapMap-based SNP pattern analysis and gene expression profiling reveals common SNP profiles for cancer therapy outcome predictor genes. Cell Cycle 5:2613-2625 (Pubitemid 44785806)
-
(2006)
Cell Cycle
, vol.5
, Issue.22
, pp. 2613-2625
-
-
Glinsky, G.V.1
-
4
-
-
33744906046
-
Genomic models of metastatic cancer: Functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway
-
Glinsky GV (2006b) Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis- enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway. Cell Cycle 5:1208-1216 (Pubitemid 43845382)
-
(2006)
Cell Cycle
, vol.5
, Issue.11
, pp. 1208-1216
-
-
Glinsky, G.V.1
-
5
-
-
45549098737
-
Stemness'' genomics law governs clinical behavior of human cancer: Implications for decision making in disease management
-
Glinsky GV (2008) ''Stemness'' genomics law governs clinical behavior of human cancer: implications for decision making in disease management. J Clin Oncol 26:2846-2853
-
(2008)
J Clin Oncol
, vol.26
, pp. 2846-2853
-
-
Glinsky, G.V.1
-
6
-
-
20444457518
-
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
-
DOI 10.1172/JCI23412
-
Glinsky GV, Berezovska O, Glinskii AB (2005) Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115:1503-1521 (Pubitemid 40814659)
-
(2005)
Journal of Clinical Investigation
, vol.115
, Issue.6
, pp. 1503-1521
-
-
Glinsky, G.V.1
Berezovska, O.2
Glinskii, A.B.3
-
8
-
-
0141871983
-
Improvement in treatment results and long-term survival of patients with esophageal cancer: Impact of chemoradiation and change in treatment strategy
-
Law S, Kwong DL, Kwok KF et al (2003) Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 238:339-347
-
(2003)
Ann Surg
, vol.238
, pp. 339-347
-
-
Law, S.1
Kwong, D.L.2
Kwok, K.F.3
-
9
-
-
32944480206
-
The expression patterns of deubiquitinating enzymes, USP22 and Usp22
-
Lee HJ, Kim MS, Shin JM et al (2006) The expression patterns of deubiquitinating enzymes, USP22 and Usp22. Gene Expr Patterns 6:277-284
-
(2006)
Gene Expr Patterns
, vol.6
, pp. 277-284
-
-
Lee, H.J.1
Kim, M.S.2
Shin, J.M.3
-
10
-
-
36448966809
-
Lymph node micrometastasis: A predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer
-
DOI 10.1007/s00595-007-3548-y
-
Li SH, Wang Z, Liu XY et al (2007) Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer. Surg Today 37:1047-1052 (Pubitemid 350165679)
-
(2007)
Surgery Today
, vol.37
, Issue.12
, pp. 1047-1052
-
-
Li, S.-H.1
Wang, Z.2
Liu, X.-Y.3
Liu, F.-Y.4
Sun, Z.-Y.5
Xue, H.6
-
11
-
-
77956478255
-
Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
-
Liu WL, Guo XZ, Zhang LJ et al (2010a) Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma. BMC Cancer 10:467-478
-
(2010)
BMC Cancer
, vol.10
, pp. 467-478
-
-
Liu, W.L.1
Guo, X.Z.2
Zhang, L.J.3
-
12
-
-
78650514966
-
Implication of USP22 in the regulation of BMI-1, c-Myc, p16INK4a, p14ARF, and cyclin D2 expression in primary colorectal carcinomas
-
Liu Y, Yang Y, Xu H et al (2010b) Implication of USP22 in the regulation of BMI-1, c-Myc, p16INK4a, p14ARF, and cyclin D2 expression in primary colorectal carcinomas. Diagn Mol Pathol 19:194-200
-
(2010)
Diagn Mol Pathol
, vol.19
, pp. 194-200
-
-
Liu, Y.1
Yang, Y.2
Xu, H.3
-
13
-
-
78149272560
-
Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer
-
Liu YL, Yang YM, Xu H et al (2010c) Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer. J Gastroenterol Hepatol 25:1800-1805
-
(2010)
J Gastroenterol Hepatol
, vol.25
, pp. 1800-1805
-
-
Liu, Y.L.1
Yang, Y.M.2
Xu, H.3
-
14
-
-
79952030196
-
Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer
-
Liu YL, Yang YM, Xu H et al (2011) Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer. J Surg Oncol 103:283-289
-
(2011)
J Surg Oncol
, vol.103
, pp. 283-289
-
-
Liu, Y.L.1
Yang, Y.M.2
Xu, H.3
-
15
-
-
78751616954
-
Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells
-
Lv L, Xiao XY, Gu ZH et al (2011) Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells. Mol Cell Biochem 346:11-21
-
(2011)
Mol Cell Biochem
, vol.346
, pp. 11-21
-
-
Lv, L.1
Xiao, X.Y.2
Zh, G.3
-
16
-
-
0037378595
-
Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease
-
DOI 10.1002/cncr.11228
-
Mariette C, Balon JM, Piessen G et al (2003) Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 97:1616-1623 (Pubitemid 36350704)
-
(2003)
Cancer
, vol.97
, Issue.7
, pp. 1616-1623
-
-
Mariette, C.1
Balon, J.-M.2
Piessen, G.3
Fabre, S.4
Van Seuningen, I.5
Triboulet, J.-P.6
-
17
-
-
38149078715
-
The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression
-
Zhang XY, Varthi M, Sykes SM et al (2008a) The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Mol Cell 29:102-111
-
(2008)
Mol Cell
, vol.29
, pp. 102-111
-
-
Zhang, X.Y.1
Varthi, M.2
Sykes, S.M.3
-
18
-
-
45849133054
-
USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A
-
Zhang XY, Pfeiffer HK, Thorne AW et al (2008b) USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A. Cell Cycle 7:1522-1524 (Pubitemid 351881314)
-
(2008)
Cell Cycle
, vol.7
, Issue.11
, pp. 1522-1524
-
-
Zhang, X.-Y.1
Pfeiffer, H.K.2
Thorne, A.W.3
McMahon, S.B.4
-
19
-
-
79961170767
-
Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer
-
Zhang Y, Yao L, Zhang X et al (2011) Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer. J Cancer Res Clin Oncol 137:1245-1253
-
(2011)
J Cancer Res Clin Oncol
, vol.137
, pp. 1245-1253
-
-
Zhang, Y.1
Yao, L.2
Zhang, X.3
|